Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Salicylaldehyde | HCID 6998 | — |
| Reactant | Potassium Hydroxide | HCID 14797 | — |
| Reactant | 1H-Indole-3-ethanamine, 5-nitro- | HCID 151295 | — |
| Reactant | Sodium borohydride | HCID 4311764 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 22722275 | HCID 22722275 | — |
Reaction Steps
5-Nitrotryptamine (6 mmol) and salicylaldehyde (7 mmol) are dissolved in ethanol (35 mL) buffered with potassium hydroxide (0.15 g) and treated with sodium borohydride (18 mmol) 8 h at 24° C. The ethanol is removed in vacuo and the residue partitioned between ether and water, the ether phase dried, evaporated and the oil chromatographed on silica gel with ethyl acetate-hexane to afford 2-{[2-(5-nitro-1H-indol-3-yl)-ethylamino]-methyl}-phenol. After hydrogenation over Pd/C as above, the residue is dissolved in pyridine (12 mL) and treated with methyl chloroformate (9 mmol). A brownish precipitate forms immediately upon addition of the chloroformate, which dissolves during 20 min. After a short time silica gel TLC (5% methanol-chloroform eluent) is performed to judge completion of the reaction. The mixture is evaporated to dryness and maintained at a vacuum of <0.1 mmHg at least 2 h. It is then dissolved in a small amount of methanol, and purified by reverse-phase HPLC with a gradient of water to methanol.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06730707B2 |
|---|
| Source dataset | uspto-grants-2004_05 |
|---|
| ORD ID | ord-b2bbcd653cdc427bb77adfb41aa279fa |
|---|
| Source note | uspto-grants-2004_05 |
|---|